RVTY Revvity, Inc.
RVTY Revvity, Inc.
Healthcare · Diagnostics & Research
Desk view
Market read
Scan convergence 1 scan as of 2026-10-23 1 bull converging
POC $97.16 · VWAP $110.88 · +43.2% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster VP + 1 other sold $248.8K, Sep 23–Oct 2
Coverage
1 watchlist
RVTY Price Structure
Loading timeframes…
Peers
Every watchlist RVTY belongs to, members best 30-day change first — RVTY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Reported the quarter ending 2026-07-05: revenue $730M, diluted EPS $0.47, net income $52M (SEC filing). Across the print the stock moved -0.2% (close before → first close after).
full note →Against street estimates
How RVTY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about RVTY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 6 days ago · Oct 17
- RVTY News Today | Why did Revvity stock go up today? $RVTY
- Revvity posts solid Q2 2026 earnings growth - TipRanks.com
- Revvity to Hold Earnings Call on November 3, 2026
- RVTY Stock Price Quote | Morningstar
- Revvity Announces Financial Results for the Second Quarter of 2026
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
RVTY research tape
46 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.